Yüklüyor......
Clinical Experience and Recent Advances in the Development of Listeria-Based Tumor Immunotherapies
The promise of tumor immunotherapy to significantly improve survival in patients who are refractory to long-standing therapies, such as chemotherapy and radiation, is now being realized. While immune checkpoint inhibitors that target PD-1 and CTLA-4 are leading the charge in clinical efficacy, there...
Kaydedildi:
| Yayımlandı: | Front Immunol |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8081050/ https://ncbi.nlm.nih.gov/pubmed/33936058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.642316 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|